UVA Light Device to Treat COVID-19

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

5 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-10-30

Study Completion Date

2020-12-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This pilot study will assess the safety and effectiveness of UV light treatment in hospitalized patients with COVID-19.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Proof-of-concept Study on Disinfection and Healing Acceleration Capabilities of 222nm Wave Length Narrow Band Ultraviolet Lighting Device

NCT03526068

Ultraviolet Rays

COMPLETED NA

Expanded Access to Convalescent Plasma to Treat and Prevent Pulmonary Complications Associated With COVID-19

NCT04358211

COVID-19

NO_LONGER_AVAILABLE

Steriwave ICU Pilot Study

NCT06867458

Ventilator Acquired Pneumonia Hospital Acquired Pneumonia Hospital Acquired Infections +1 more

NOT_YET_RECRUITING NA

Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19

NCT04567173

Covid19

TERMINATED PHASE2/PHASE3

Preventing Respiratory Viral Illness Invisibly

NCT05084898

COVID-19 Respiratory Infection Respiratory Virus Infection Influenza -Like Illness

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a single center, open label, pilot study. 5 adult patients, aged over 18, who are confirmed positive with SARS-CoV-2 and are newly intubed, will receive UV light treatment to reduce SARS-CoV-2 viral load.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronavirus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Intubated patients with confirmed SARS-CoV-2 will receive UV light treatment to potentially reduce bacterial and viral burden.

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Endotracheal UV Light

Mechanically ventilated patients who will receive UV Light therapy

Group Type EXPERIMENTAL

UV Light Treatment

Intervention Type DEVICE

UV light therapy administered while patient is mechanically ventilated

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

UV Light Treatment

UV light therapy administered while patient is mechanically ventilated

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Confirmed positive test result for SARS-CoV-2
* Mechanically ventilated
* Endotracheal tube inner diameter of at least 7.5 mm

Exclusion Criteria

* Unable to provide informed consent (or surrogate)
* Enrolled in a therapeutic clinical trial for same condition that does not allow recruitment in other trials
* Pregnant women

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No